Zi Qin Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zi Qin Ng has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Hugo C. Temperley
St James’s Hospital
10 shared publications Ruwan Wijesuriya
Department of General Surgery, St John of God Midland Hospital, Midland 6056, Western Australia, Australia
10 shared publicationsSatish Warrier
Department of General Surgery, Colorectal Unit, The Alfred, Melbourne, Victoria, Australia
10 shared publications- Benjamin M. Mac Curtain
Northwell Health, New Hyde Park, NY 11040, USA
8 shared publications Mary Theophilus
Department of General Surgery Royal Perth Hospital Perth Western Australia Australia
7 shared publicationsJih Huei Tan
Department of General Surgery, Hospital Sultanah Aminah, Johor Bahru, Malaysia
5 shared publications
Latest Publications
- 5 November 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 328, 601-614
Defining Retroperitoneal Lymph Node Dissection: A Systematic Review of Anatomical Landmarks and TemplateTerminology
- 5 November 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 328, 601-614
Defining Retroperitoneal Lymph Node Dissection: A Systematic Review of Anatomical Landmarks and TemplateTerminology
- Open Access
- 13 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3322
Radiomics-Based Outcome Prediction in Transarterial Radioembolization (TARE) of Hepatic Malignancies: A Systematic Review and Quality Appraisal
Background: Transarterial radioembolization (TARE) with Yttrium-90 (90Y) microspheres is an established locoregional treatment for primary and secondary hepatic malignancies. Treatment response is heterogeneous, and accurate pre-procedural prediction of outcome remains a clinical challenge. Radiomics, defined as the high-throughput extraction of quantitative imaging features, may capture subvisual tumour heterogeneity that might be predictive of response, therefore enabling individualised patient selection and treatment planning. Objectives: To systematically review the current evidence on radiomics-based models derived from pre- and post-procedural imaging for predicting treatment response and survival outcomes in patients with primary and secondary hepatic lesions that were treated with TARE, and to evaluate the methodological quality of included studies. Methods: A systematic literature search was conducted across PubMed, Embase, Scopus, and Web of Science. Studies reporting radiomics, texture analysis, dosiomics, or machine learning applied to imaging in patients with hepatic lesions treated with TARE, with at least one reported performance metric, were included. Methodological quality was assessed using the Radiomics Quality Score (RQS) and risk of bias and applicability using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Due to substantial heterogeneity, a narrative synthesis was performed. Results: Twenty-one studies encompassing 1734 patients were included (up to 73 patients may be counted twice because two cohorts overlap). Studies evaluated patients with hepatocellular carcinoma (HCC; n = 12), intrahepatic cholangiocarcinoma (iCC; n = 2), colorectal cancer liver metastases (CLMs; n = 3), and mixed tumour cohorts (n = 4). Imaging modalities included MRI (n = 9), CT (n = 5), 18F-FDG PET or PET/CT (n = 3), 90Y PET or SPECT (n = 2), cone-beam CT (n = 1), and CT perfusion (n = 1). All studies were retrospective, including two post hoc analyses of randomised trial cohorts, and none used external validation. Eighteen studies reported an area under the curve (AUC). The highest reported AUC ranged from 0.71 to 0.90 in eight studies with no validation, from 0.73 to 1.00 in six studies using internal cross-validation, and from 0.80 to 0.90 in four studies using an internal hold-out set. The median RQS was 2 (interquartile range 1 to 5; maximum 36), and all 21 studies had a high overall risk of bias on PROBAST. Conclusions: Radiomic models for predicting TARE outcomes show moderate to high apparent discrimination, but the evidence comes from small retrospective cohorts, is at high risk of bias, and has not been externally validated. Adding clinical variables to radiomic features produced only small gains. Prospective, multi-centre studies with standardised segmentation, harmonised radiomics pipelines, and robust external validation are needed before routine clinical adoption.
- 13 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3322
Open AccessRadiomics-Based Outcome Prediction in Transarterial Radioembolization (TARE) of Hepatic Malignancies: A Systematic Review and Quality Appraisal
Background: Transarterial radioembolization (TARE) with Yttrium-90 (90Y) microspheres is an established locoregional treatment for primary and secondary hepatic malignancies. Treatment response is heterogeneous, and accurate pre-procedural prediction of outcome remains a clinical challenge. Radiomics, defined as the high-throughput extraction of quantitative imaging features, may capture subvisual tumour heterogeneity that might be predictive of response, therefore enabling individualised patient selection and treatment planning. Objectives: To systematically review the current evidence on radiomics-based models derived from pre- and post-procedural imaging for predicting treatment response and survival outcomes in patients with primary and secondary hepatic lesions that were treated with TARE, and to evaluate the methodological quality of included studies. Methods: A systematic literature search was conducted across PubMed, Embase, Scopus, and Web of Science. Studies reporting radiomics, texture analysis, dosiomics, or machine learning applied to imaging in patients with hepatic lesions treated with TARE, with at least one reported performance metric, were included. Methodological quality was assessed using the Radiomics Quality Score (RQS) and risk of bias and applicability using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Due to substantial heterogeneity, a narrative synthesis was performed. Results: Twenty-one studies encompassing 1734 patients were included (up to 73 patients may be counted twice because two cohorts overlap). Studies evaluated patients with hepatocellular carcinoma (HCC; n = 12), intrahepatic cholangiocarcinoma (iCC; n = 2), colorectal cancer liver metastases (CLMs; n = 3), and mixed tumour cohorts (n = 4). Imaging modalities included MRI (n = 9), CT (n = 5), 18F-FDG PET or PET/CT (n = 3), 90Y PET or SPECT (n = 2), cone-beam CT (n = 1), and CT perfusion (n = 1). All studies were retrospective, including two post hoc analyses of randomised trial cohorts, and none used external validation. Eighteen studies reported an area under the curve (AUC). The highest reported AUC ranged from 0.71 to 0.90 in eight studies with no validation, from 0.73 to 1.00 in six studies using internal cross-validation, and from 0.80 to 0.90 in four studies using an internal hold-out set. The median RQS was 2 (interquartile range 1 to 5; maximum 36), and all 21 studies had a high overall risk of bias on PROBAST. Conclusions: Radiomic models for predicting TARE outcomes show moderate to high apparent discrimination, but the evidence comes from small retrospective cohorts, is at high risk of bias, and has not been externally validated. Adding clinical variables to radiomic features produced only small gains. Prospective, multi-centre studies with standardised segmentation, harmonised radiomics pipelines, and robust external validation are needed before routine clinical adoption.
- Open Access
- 2 October 2026
- Published by Springer Nature in European Radiology Abdomen
- Vol. 1 (1) , 8
PET/CT-first staging in anal cancer: reconsidering the role of routine MRI
- 2 October 2026
- Published by Springer Nature in European Radiology Abdomen
- Vol. 1 (1) , 8
Open AccessPET/CT-first staging in anal cancer: reconsidering the role of routine MRI
- Open Access
- 27 September 2026
- Published by Wiley in Anz Journal of Surgery
How to Do a Laparoscopic Iliac Lymph Node Biopsy Under Indocyanine Green ( ICG ) Guidance
Isolated abdominal lymphadenopathy can be difficult to diagnose when lesions are inaccessible to percutaneous biopsy. We describe a laparoscopic common iliac lymph node biopsy performed using indocyanine green (ICG) fluorescence guidance. A 67‐year‐old woman with bilateral lower limb oedema was found to have an FDG‐avid right common iliac lymph node causing ureteric compression and deep venous thrombosis. Following ultrasound‐guided inguinal node ICG injection, near‐infrared fluorescence imaging enabled localisation of the target node. Intravenous ICG further delineated adjacent iliac vessels, facilitating safe dissection and biopsy. Histology demonstrated reactive follicular hyperplasia. ICG fluorescence imaging may improve the safety and accuracy of laparoscopic intra‐abdominal lymph node biopsy.
- 27 September 2026
- Published by Wiley in Anz Journal of Surgery
Open AccessHow to Do a Laparoscopic Iliac Lymph Node Biopsy Under Indocyanine Green ( ICG ) Guidance
Isolated abdominal lymphadenopathy can be difficult to diagnose when lesions are inaccessible to percutaneous biopsy. We describe a laparoscopic common iliac lymph node biopsy performed using indocyanine green (ICG) fluorescence guidance. A 67‐year‐old woman with bilateral lower limb oedema was found to have an FDG‐avid right common iliac lymph node causing ureteric compression and deep venous thrombosis. Following ultrasound‐guided inguinal node ICG injection, near‐infrared fluorescence imaging enabled localisation of the target node. Intravenous ICG further delineated adjacent iliac vessels, facilitating safe dissection and biopsy. Histology demonstrated reactive follicular hyperplasia. ICG fluorescence imaging may improve the safety and accuracy of laparoscopic intra‐abdominal lymph node biopsy.
- Open Access
- 20 September 2026
- Published by Wiley in Anz Journal of Surgery
Adhesive Bowel Obstruction Following Discontinuation of Gastrografin: Time for an Alternative Pathway
- 20 September 2026
- Published by Wiley in Anz Journal of Surgery
Open AccessAdhesive Bowel Obstruction Following Discontinuation of Gastrografin: Time for an Alternative Pathway
- Open Access
- 28 July 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (10) , 4917-4923
Management of parastomal variceal bleeding in an adult with metastatic liver cancer: A case-based review
- 28 July 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (10) , 4917-4923
Open AccessManagement of parastomal variceal bleeding in an adult with metastatic liver cancer: A case-based review
- Open Access
- 30 May 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1)
Safety and feasibility of early discharge (≤ 23 h) following loop ileostomy reversal: a systematic review and meta-analysis
Background: The standard practice for postoperative management of loop ileostomy reversal has been standard admission with several days of inpatient observation, largely to monitor for postoperative complications. These primarily include anastomotic leak, postoperative ileus, and surgical site infection. In recent years, several studies have piloted ambulatory or short-stay pathways; however, the safety and impact of these pathways on complications remains unclear. Methods: This systematic review and meta-analysis was conducted in accordance with PRISMA. It was also conducted in accordance with a prospectively registered protocol (PROSPERO CRD420251252408). Adults undergoing loop ileostomy reversal discharged within 23 h of surgery (including same-day discharge (SDD), short-stay protocols (LOS 1)) were compared with patients managed with standard admission. Primary outcomes were anastomotic leak, postoperative ileus, and surgical site infection at 30 postoperative days; secondary outcomes included readmission, overall complications including Clavien-Dindo-graded events, and mortality. Random-effects models were used to pool odds ratios with 95% confidence intervals. Results: Twelve studies (11 retrospective cohort studies, 1 RCT), comprising 30,040 patients were included. Of these, 2611 (8.7%) patients underwent ambulatory or short-stay reversal. There was no significant difference between early discharge and standard cohorts in anastomotic leak (pooled OR 1.31, 95% CI 0.24–7.32), postoperative ileus (pooled OR 0.49, 95% CI 0.16–1.55), or surgical site infection (pooled OR 0.76, 95% CI 0.38–1.51). However, the low event rates and wide Cis likely preclude confident exclusion of a clinically meaningful effect. Similarly, readmission rates showed no difference between groups (pooled OR 0.97, 95% CI 0.78–1.19). Early discharge following reversal was, however, associated with a modest but statistically significant reduction in overall postoperative complications (pooled OR 0.70, 95% CI 0.50–0.98), with comparable rates of major (Clavien-Dindo III–IV) complications and very low mortality in both groups. Conclusions: This study suggests that early discharge following loop ileostomy reversal, if carried out as part of a structured perioperative pathway, appears to be safe, with no apparent increase in risk of any additional postoperative complications. However, the data available at present is dominated by largely retrospective cohort studies, with heterogenous discharge criteria, and inconsistency in intervention (SDD vs 23 h stay vs short-stay protocol), precluding any firm conclusions regarding equivalence with standard admission. Rather than advocating for its widespread adoption, these findings support the cautious implementation of early discharge pathways in select cohorts with prospectively collected outcomes. Adequately powered multicentre RCTs with standardisation of intervention and outcome measures are required before broader dissemination can be recommended. Clinical trial registration: Not applicable. This study is not a clinical trial.
- 30 May 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1)
Open AccessSafety and feasibility of early discharge (≤ 23 h) following loop ileostomy reversal: a systematic review and meta-analysis
Background: The standard practice for postoperative management of loop ileostomy reversal has been standard admission with several days of inpatient observation, largely to monitor for postoperative complications. These primarily include anastomotic leak, postoperative ileus, and surgical site infection. In recent years, several studies have piloted ambulatory or short-stay pathways; however, the safety and impact of these pathways on complications remains unclear. Methods: This systematic review and meta-analysis was conducted in accordance with PRISMA. It was also conducted in accordance with a prospectively registered protocol (PROSPERO CRD420251252408). Adults undergoing loop ileostomy reversal discharged within 23 h of surgery (including same-day discharge (SDD), short-stay protocols (LOS 1)) were compared with patients managed with standard admission. Primary outcomes were anastomotic leak, postoperative ileus, and surgical site infection at 30 postoperative days; secondary outcomes included readmission, overall complications including Clavien-Dindo-graded events, and mortality. Random-effects models were used to pool odds ratios with 95% confidence intervals. Results: Twelve studies (11 retrospective cohort studies, 1 RCT), comprising 30,040 patients were included. Of these, 2611 (8.7%) patients underwent ambulatory or short-stay reversal. There was no significant difference between early discharge and standard cohorts in anastomotic leak (pooled OR 1.31, 95% CI 0.24–7.32), postoperative ileus (pooled OR 0.49, 95% CI 0.16–1.55), or surgical site infection (pooled OR 0.76, 95% CI 0.38–1.51). However, the low event rates and wide Cis likely preclude confident exclusion of a clinically meaningful effect. Similarly, readmission rates showed no difference between groups (pooled OR 0.97, 95% CI 0.78–1.19). Early discharge following reversal was, however, associated with a modest but statistically significant reduction in overall postoperative complications (pooled OR 0.70, 95% CI 0.50–0.98), with comparable rates of major (Clavien-Dindo III–IV) complications and very low mortality in both groups. Conclusions: This study suggests that early discharge following loop ileostomy reversal, if carried out as part of a structured perioperative pathway, appears to be safe, with no apparent increase in risk of any additional postoperative complications. However, the data available at present is dominated by largely retrospective cohort studies, with heterogenous discharge criteria, and inconsistency in intervention (SDD vs 23 h stay vs short-stay protocol), precluding any firm conclusions regarding equivalence with standard admission. Rather than advocating for its widespread adoption, these findings support the cautious implementation of early discharge pathways in select cohorts with prospectively collected outcomes. Adequately powered multicentre RCTs with standardisation of intervention and outcome measures are required before broader dissemination can be recommended. Clinical trial registration: Not applicable. This study is not a clinical trial.
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Colo-Rectal Surgery
- Vol. 9 (2) , 82-88
The Initial Experience in Adopting Laparoscopic Right Colectomy with Complete Mesocolic Excision through a Learning Curriculum
A BSTRACT: Introduction: Laparoscopic right colectomy with complete mesocolic excision (CME) is increasingly adopted across the globe due to studies showing improved long-term survival outcomes. However, major vascular injury is the main cited reason against routine CME being performed. We aim to evaluate our early experience of laparoscopic right colectomy with CME through a structured learning curriculum. Methods: Prospective data collection was performed from January 2024 to February 2025 for all laparoscopic right colectomy with CME. Data collated included patient demographics, comorbidities, pathology, intra- and postoperative outcomes, and histopathology outcomes. Results: During the study period, there were 12 cases of CME performed. There were 8 female and 4 male patients. The median age was 73 years (range: 64–86). The median American Society of Anesthesiologists was 3 (2–3). The median body mass index was 25.1 (range: 20.8–37.8). Of the 12 cases, there were 10 laparoscopic right colectomy with CME cases, 1 extended right colectomy with CME, and 1 synchronous laparoscopic right colectomy with CME with low anterior resection and diverting loop ileostomy. There was one conversion to open due to bleeding at the gastro-omental vessel. This was managed with oversewing. There was no injury to the Trunk of Henle/SMV/SMA. There was no anastomotic leak. All cases achieved R0 resection, and the median lymph node yield was 29 (range: 16–70). There was no mortality. Conclusion: Laparoscopic right colectomy with CME can be safely introduced into clinical practice through a structured learning curriculum. Further long-term oncological outcomes need to be evaluated for CME.
- 1 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Colo-Rectal Surgery
- Vol. 9 (2) , 82-88
Open AccessThe Initial Experience in Adopting Laparoscopic Right Colectomy with Complete Mesocolic Excision through a Learning Curriculum
A BSTRACT: Introduction: Laparoscopic right colectomy with complete mesocolic excision (CME) is increasingly adopted across the globe due to studies showing improved long-term survival outcomes. However, major vascular injury is the main cited reason against routine CME being performed. We aim to evaluate our early experience of laparoscopic right colectomy with CME through a structured learning curriculum. Methods: Prospective data collection was performed from January 2024 to February 2025 for all laparoscopic right colectomy with CME. Data collated included patient demographics, comorbidities, pathology, intra- and postoperative outcomes, and histopathology outcomes. Results: During the study period, there were 12 cases of CME performed. There were 8 female and 4 male patients. The median age was 73 years (range: 64–86). The median American Society of Anesthesiologists was 3 (2–3). The median body mass index was 25.1 (range: 20.8–37.8). Of the 12 cases, there were 10 laparoscopic right colectomy with CME cases, 1 extended right colectomy with CME, and 1 synchronous laparoscopic right colectomy with CME with low anterior resection and diverting loop ileostomy. There was one conversion to open due to bleeding at the gastro-omental vessel. This was managed with oversewing. There was no injury to the Trunk of Henle/SMV/SMA. There was no anastomotic leak. All cases achieved R0 resection, and the median lymph node yield was 29 (range: 16–70). There was no mortality. Conclusion: Laparoscopic right colectomy with CME can be safely introduced into clinical practice through a structured learning curriculum. Further long-term oncological outcomes need to be evaluated for CME.
- 21 January 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (9) , 2264-2266
Indocyanine Green Fluorescence Cholangiography in Minimally Invasive Cholecystectomy: Routine Practice or Selective Adjunct?
- 21 January 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (9) , 2264-2266
Indocyanine Green Fluorescence Cholangiography in Minimally Invasive Cholecystectomy: Routine Practice or Selective Adjunct?
- 20 January 2026
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 69 (4) , 546-550
Acute Diverticulitis in Immunosuppressed Patients
- 20 January 2026
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 69 (4) , 546-550
Acute Diverticulitis in Immunosuppressed Patients